Inhibition of von Willebrand factor binding to activated platelets by the tetrapeptide ARG-GLY-ASP-SER and the dodecapeptide of fibrinogen gamma chains: HR Gralnick, SB Williams, and J Hawiger. National Institutes of Health. Bethesda MD and New England Deaconess Hospital and Harvard Medical School, Boston, MA